Thomas Louie
ORCID:0000-0003-2131-0158
发表论文 205 篇 · 总被引 15151 次 · h-index 57
代表论文
- VE303, a Defined Bacterial Consortium, for Prevention of Recurrent Clostridioides difficile Infection (2023 · JAMA · 被引 196)
- Metabolic independence drives gut microbial colonization and resilience in health and disease (2023 · Genome biology · 被引 103)
- Insights into the Evolving Epidemiology of Clostridioides difficile Infection and Treatment: A Global Perspective (2023 · Antibiotics · 被引 69)
- A Randomized, Double-Blind, Phase 3 Safety and Efficacy Study of Ridinilazole Versus Vancomycin for Treatment of Clostridioides difficile Infection: Clinical Outcomes With Microbiome and Metabolome Correlates of Response (2024 · Clinical Infectious Diseases · 被引 35)
- Prevalence of Comorbid Factors in Patients With Recurrent Clostridioides difficile Infection in ECOSPOR III, a Randomized Trial of an Oral Microbiota–Based Therapeutic (2023 · Clinical Infectious Diseases · 被引 24)
- Safety and Tolerability of CP101, a Full-Spectrum, Oral Microbiome Therapeutic for the Prevention of Recurrent Clostridioides difficile Infection: A Phase 2 Randomized Controlled Trial (2024 · Gastroenterology · 被引 19)